Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RIOK2-IN-1 (com 4) is a selective RIOK2 inhibitor with a Kd of 150 nM, though it demonstrates low cellular activity with an IC50 of 14,600 nM. As an atypical kinase, RIOK2's involvement in ribosome maturation and cell cycle progression associates it with various human cancers. The derivative compound CQ211, an enhanced version of RIOK2-IN-1, exhibits robust in vivo and in vitro efficacy. It effectively inhibits the proliferation of MKN-1 and HT-29 cancer cell lines and hinders tumor growth in the MKN-1 mouse xenograft model [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | RIOK2-IN-1 (com 4) is a selective RIOK2 inhibitor with a Kd of 150 nM, though it demonstrates low cellular activity with an IC50 of 14,600 nM. As an atypical kinase, RIOK2's involvement in ribosome maturation and cell cycle progression associates it with various human cancers. The derivative compound CQ211, an enhanced version of RIOK2-IN-1, exhibits robust in vivo and in vitro efficacy. It effectively inhibits the proliferation of MKN-1 and HT-29 cancer cell lines and hinders tumor growth in the MKN-1 mouse xenograft model [1]. |
Molecular Weight | 276.33 |
Formula | C18H16N2O |
CAS No. | 1088216-72-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RIOK2-IN-1 1088216-72-1 inhibitor inhibit